Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antivet vs Opalustre for Dental Fluorosis
NCT06949878Phase 4Not yet recruiting
- Sponsor
- Cairo University
- Start
- May 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of Antivet in dental fluorosis (2 arms), sponsored by Cairo University. Primary endpoint: Clinical assessment of treatment success at 6 months. Planned start May 2025; status: not yet recruiting.
02
Drugs
Antivet
03
Conditions
dental fluorosis
Beyond the preview
Go deeper on NCT06949878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06949878.